Statin drugs inhibit HMGCR and this can modulate several cellular signaling pathways relevant to tumor formation, including angiogenesis, cellular proliferation, cell cycle regulation, gene expression, metastatic potential, and cell death5, 16, 17, 18. Here, HMGCR is linked to neoplasm.